These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10718125)

  • 1. Pharmacodynamic analysis between plasma level and inhibition of acid output after administration of a new histamine H2-receptor antagonist (Z-300) in dog.
    Furuta S; Sugimoto T; Suzuki M; Yoneta T; Hori Y; Morita H; Aita H; Sano H
    Xenobiotica; 2000 Feb; 30(2):193-9. PubMed ID: 10718125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
    Okabe S; Takagi K; Igata H; Kato S; Shimosako K; Yamaji Y; Seiki M
    Jpn J Pharmacol; 1992 Jul; 59(3):275-89. PubMed ID: 1359178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic properties of lafutidine after postprandial oral administration in healthy subjects: comparison with famotidine.
    Ikawa K; Shimatani T; Hayato S; Morikawa N; Tazuma S
    Biol Pharm Bull; 2007 May; 30(5):1003-6. PubMed ID: 17473452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a new histamine H2-receptor antagonist, Z-300, in rat and dog.
    Sugimoto T; Furuta S; Kawamata H; Suzuki M; Sano H; Ito T; Hirabayashi N; Imamura F; Matsuki Y
    Xenobiotica; 1999 Apr; 29(4):425-33. PubMed ID: 10375011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism.
    Nakano M; Kitano S; Nanri M; Kiniwa M
    Eur J Pharmacol; 2011 May; 658(2-3):236-41. PubMed ID: 21349265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
    Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
    Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin gene-related peptide and somatostatin releases correlated with the area under the lafutidine concentration-time curve in human plasma.
    Ikawa K; Shimatani T; Azuma Y; Inoue M; Morikawa N
    J Clin Pharm Ther; 2006 Aug; 31(4):351-6. PubMed ID: 16882104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of BMY-25368, a potent and long-acting histamine H2-receptor antagonist, on gastric secretion and aspirin-induced gastric lesions in the dog.
    Cavanagh RL; Buyniski JP
    Aliment Pharmacol Ther; 1989 Jun; 3(3):299-313. PubMed ID: 2577694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of IT-066, a new histamine H2-receptor antagonist, on gastric acid secretion and experimental gastric ulcers in rats and dogs].
    Okabe S; Nishida T; Igata H; Takagi K
    Nihon Yakurigaku Zasshi; 1990 May; 95(5):247-56. PubMed ID: 1972370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Z-300, a new histamine H2-receptor antagonist, on mucin biosynthesis in rat gastric mucosa.
    Ichikawa T; Ishihara K; Ogata Y; Ohara S; Saigenji K; Hotta K
    Jpn J Pharmacol; 1994 May; 65(1):63-6. PubMed ID: 7916385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
    Lin JH
    Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
    Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
    Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of a new histamine H2-receptor antagonist, Z-300, in rat.
    Sugimoto T; Furuta S; Suzuki M; Sano H
    Xenobiotica; 1999 Aug; 29(8):803-14. PubMed ID: 10553721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
    Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
    Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antisecretory potency and duration of action of the H2-receptor antagonists AH 22216, cimetidine, ranitidine and SK & F 93479 in the dog.
    Stables R; Daly MJ; Humphray JM
    Agents Actions; 1983 Apr; 13(2-3):166-9. PubMed ID: 6135321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the new histamine H2 receptor antagonist, FRG-8813, on gastric mucin in rats with or without acidified ethanol-induced gastric damage.
    Ichikawa T; Ishihara K; Komuro Y; Kojima Y; Saigenji K; Hotta K
    Life Sci; 1994; 54(10):PL159-64. PubMed ID: 7509019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel histamine 2(H2) receptor antagonist with gastroprotective activity. II. Synthesis and pharmacological evaluation of 2-furfuryl-thio and 2-furfurylsulfinyl acetamide derivatives with heteroaromatic rings.
    Hirakawa N; Matsumoto H; Hosoda A; Sekine A; Yamaura T; Sekine Y
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):616-22. PubMed ID: 9579037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
    Shibata M; Yamaura T; Sekine A; Nishikawa M; Chida Y; Ohnishi H
    Jpn J Pharmacol; 1990 Nov; 54(3):277-85. PubMed ID: 1982548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency.
    Gladziwa U; Wagner S; Sieberth HG; Klotz U
    Br J Clin Pharmacol; 1995 Feb; 39(2):161-7. PubMed ID: 7742154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of FRG-8813, a new type histamine H2-receptor antagonist, on various experimental gastric and duodenal lesions in rats].
    Yamaura T; Shibata M; Inaba N; Onodera S; Chida Y; Ohnishi H
    Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):401-10. PubMed ID: 1356897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.